QUMAS Growth Through 2012

(firmenpresse) - CORK, IRELAND -- (Marketwire) -- 01/31/13 -- QUMAS today announced significant growth through 2012, providing further evidence of its leadership position in Quality, Regulatory and Compliance Management across Life Sciences. The company delivered 25% growth in revenues in 2012 and grew its client base significantly.

QUMAS continued to add new names to its client list in 2012, including Polypeptide, Aveo, Revance, Samsung Bioepis, Pharmacyclics, Coating Place, PharmaNet/i3, ZioPharm, Emergent Biosolutions, Shionogi, and Alvogen. A number of these new clients have deployed and gone live with QUMAS ComplianceSP on Microsoft SharePoint 2010. Among other deals, QUMAS was engaged by a top 10 global biopharmaceutical company in 2012 to replace a legacy eDMS with the QUMAS Compliance Platform.

"This significant strengthening of our client base over the last 12 months reflects our continuing drive to be the dominant player in the space. This is further evidenced by the successful delivery of ComplianceSP, our SharePoint 2010-based solution," said Kevin O'Leary, CEO, QUMAS. "New client opportunities were up threefold in 2012 on 2011, and we're continuing to see significant growth in our pipeline."

The QUMAS Compliance Platform delivers comprehensive document, content and process management to the Regulatory, Quality and Compliance groups across Life Sciences, driving regulatory compliance and ultimately delivering business performance improvements.

QUMAS will be announcing a series of new client acquisitions over coming weeks.

QUMAS is the leader in Compliance Solutions with more than 270 global customer deployments and two decades of experience in highly regulated industries.

QUMAS is a Gold Microsoft Partner, and provides the QUMAS Compliance Platform on SharePoint 2010, Oracle or SQL. For more information, visit





MEDIA CONTACT:

Caoimhe Kiely
VP Marketing
QUMAS

+353 21 4915100

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 31.01.2013 - 12:32 Uhr
Sprache: Deutsch
News-ID 224879
Anzahl Zeichen: 0

contact information:
Town:

CORK, IRELAND

Kategorie:

Medical Devices

Diese Pressemitteilung wurde bisher 257 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"QUMAS Growth Through 2012"
steht unter der journalistisch-redaktionellen Verantwortung von

QUMAS (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Leading Biopharmaceutical Company Chooses Cloud-Based QUMAS ComplianceSP on Shar ...

JERSEY CITY, NJ -- (Marketwired) -- 11/12/13 -- , the leading provider of regulatory, quality, and compliance management solutions to the Life Sciences industry, today announced that a leading biopharmaceutical company in Cambridge, Massachusetts ha ...

Scandinavian Health Ltd. Selects QUMAS ComplianceSP on SharePoint 2010 for Regul ...

CORK, IRELAND -- (Marketwired) -- 09/04/13 -- , the leading provider of regulatory, quality, and compliance management solutions to the Life Sciences industry, today announced that (SHL), the world's largest privately-owned designer, developer ...

Quality Management Solution From QUMAS Delivers Extended Control Across Manufact ...

CORK, IRELAND -- (Marketwired) -- 08/29/13 -- , the leading provider of regulatory, quality, and compliance management solutions to the Life Sciences industry, today announced that it has released QUMAS . The advanced features in the new release of ...

Alle Meldungen von QUMAS